Breast cancer patients were considering removing their ovaries until the maker of Zoladex 3.6mg said they would give the drug ...

Ashleigh Middleton has spent months campaigning to keep a drug that's holding her cancer at bay on Australian shelves. Now ...

A drug used to treat patients with life-threatening illnesses has received an important update after substantial community ...

Last month, pharmaceutical giant AstraZeneca – the maker of Goserelin, AKA Zoladex – announced it would pull the life-saving breast cancer and endometriosis drug from the Pharmaceutical Benefits ...

UCHealth is slicing the cost of a cancer drug after acknowledging it had been overcharging patients and insurance companies for years. The move, following a Coloradoan investigation into the health ...

People living with hormone receptor‑positive breast cancer, endometriosis and adenomyosis are facing new uncertainty after confirmation that a medication many rely on will be taken off the market in ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ZOLADEX 10.8 mg contains the active ingredient goserelin acetate.

A life-saving breast cancer and endometriosis drug will be pulled from Australian shelves by a major global drug manufacturer later this year, in a move some women have described as "cruel" and ...

TerSera has obtained Health Canada's approval for a supplemental new drug submission for ZOLADEX LA (goserelin acetate) 10.8mg administered every 12 weeks to manage oestrogen receptor-positive (ER+) ...